Avalon Celebrates 25 Years of Excellence: A Journey of Innovation and Commitment
Duphat 2024: Avalon Pharma's Exciting Contribution to the Pharmaceutical Summit
Avalon Pharmaceutical's ACE Plan: Navigating Towards SAR 1 Billion Revenue by 2030
Elevates Corporate Structure: Transition from LTD to JSC
Avalon Pharmaceutical Takes Center Stage at Saudi Made Exhibition: A Showcase of Innovation and National Pride
Avalon's Remarkable Presence at the Global Health Exhibition
Avalon Pharmaceutical Gears Up for DUPHAT 2024
Avalon Pharma Celebrates Successful Participation at Arab Health 2024